Publications by authors named "Simona Malucchi"

Claim this Profile
D
Disease Course in Patients Switched from Natalizumab to Alemtuzumab: An Italian Multicenter, Prospective, Observational Study.
Simona Malucchi, Paola Perini, Francesca Rinaldi, Marta Radaelli, Maria Malentacchi

Neurol Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: In multiple sclerosis patients a single serum neurofilament light chain (sNFL) dosage is strongly associated with 12 months outcome: data from a real-life clinical setting.
Simona Malucchi, Cecilia Irene Bava, Paola Valentino, Serena Martire, Marianna Lo Re

J Neurol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A disease-specific convergence of host and Epstein-Barr virus genetics in multiple sclerosis.
Rosella Mechelli, Renato Umeton, Gianmarco Bellucci, Rachele Bigi, Virginia Rinaldi, Simona Malucchi

Proc Natl Acad Sci U S A· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In multiple sclerosis patients a single serum neurofilament light chain (sNFL) dosage is strongly associated with 12 months outcome: data from a real-life clinical setting.
Simona Malucchi, Cecilia Irene Bava, Paola Valentino, Serena Martire, Marianna Lo Re

J Neurol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of elevated sNFL in a real-world setting: Results on 908 patients with different multiple sclerosis types and treatment conditions.
Cecilia Irene Bava, Paola Valentino, Simona Malucchi, Rugiada Bottero, Serena Martire

Mult Scler Relat Disord· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous or subcutaneous natalizumab in patients with relapsing-remitting multiple sclerosis: investigation on efficiency and savings-the EASIER study.
Massimo Filippi, Luigi Grimaldi, Antonella Conte, Rocco Totaro, Maria Rosaria Valente, Simona Malucchi

J Neurol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose.
Massimiliano Di Filippo, Diana Ferraro, Paolo Ragonese, Luca Prosperini, Giorgia Teresa Maniscalco, Simona Malucchi

J Neurol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study.
Maria Pia Amato, Roberto Bergamaschi, Diego Centonze, Massimiliano Mirabella, Girolama Alessandra Marfia, Simona Malucchi

J Neurol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tailoring Rituximab According to CD27-Positive B-Cell versus CD19-Positive B-Cell Monitoring in Neuromyelitis Optica Spectrum Disorder and MOG-Associated Disease: Results from a Single-Center Study.
Nicolò Bruschi, Maria Malentacchi, Simona Malucchi, Francesca Sperli, Serena Martire

Neurol Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with multiple sclerosis choose a collaborative role in making treatment decision: results from the Italian multicenter SWITCH study.
Francesco Patti, Clara Grazia Chisari, Simona Toscano, Pietro Annovazzi, Paola Banfi, Simona Malucchi

Mult Scler Relat Disord· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
sNFL applicability as additional monitoring tool in natalizumab extended interval dosing regimen for RRMS patients.
Paola Valentino, Simona Malucchi, Serena Martire, Cecilia Irene Bava, Marco Alfonso Capobianco

Mult Scler Relat Disord· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis.
Doriana Landi, Francesca Bovis, Alfonso Grimaldi, Pietro Osvaldo Annovazzi, Antonio Bertolotto, Simona Malucchi

J Neurol Neurosurg Psychiatry· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis.
Massimiliano Di Filippo, Cinzia Cordioli, Simona Malucchi, Pietro Annovazzi, Paola Cavalla

J Neurol Neurosurg Psychiatry· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study.
Pietro Iaffaldano, Giuseppe Lucisano, Alessia Manni, Damiano Paolicelli, Francesco Patti, Simona Malucchi

Neurol Neuroimmunol Neuroinflamm· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum neurofilament light chain levels in healthy individuals: A proposal of cut-off values for use in multiple sclerosis clinical practice.
Paola Valentino, Fabiana Marnetto, Serena Martire, Simona Malucchi, Cecilia Irene Bava

Mult Scler Relat Disord· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fingolimod as first-line treatment in pediatric-onset multiple sclerosis: a case report.
Marco Capobianco, Antonio Bertolotto, Simona Malucchi

Neurol Sci· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.
Chiara Zecca, Francesca Bovis, Giovanni Novi, Marco Capobianco, Roberta Lanzillo, Simona Malucchi

Mult Scler· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study).
Francesco Patti, Clara Grazia Chisari, Emanuele D'Amico, Pietro Annovazzi, Paola Banfi, Simona Malucchi

Mult Scler Relat Disord· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.
Giovanni Novi, Francesca Bovis, Marco Capobianco, Jessica Frau, Giorgia Mataluni, Simona Malucchi

Mult Scler Relat Disord· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study.
Massimiliano Calabrese, Claudio Gasperini, Carla Tortorella, Gianmarco Schiavi, Giovanni Frisullo, Simona Malucchi

Neurology· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study.
Roberta Lanzillo, Luca Prosperini, Claudio Gasperini, Marcello Moccia, Roberta Fantozzi, Simona Malucchi

J Neurol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effectiveness of a Body-Affective Mindfulness Intervention for Multiple Sclerosis Patients with Depressive Symptoms: A Randomized Controlled Clinical Trial.
Sara Carletto, Valentina Tesio, Martina Borghi, Diana Francone, Francesco Scavelli, Simona Malucchi

Front Psychol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological activity of glatiramer acetate on Treg and anti-inflammatory monocytes persists for more than 10years in responder multiple sclerosis patients.
Michela Spadaro, Francesca Montarolo, Simona Perga, Serena Martire, Federica Brescia, Simona Malucchi

Clin Immunol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study.
Simona Malucchi, Marco Capobianco, Marianna Lo Re, Maria Malentacchi, Alessia di Sapio

Neurol Ther· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decline of Neuropsychological Abilities in a Large Sample of Patients with Multiple Sclerosis: A Two-Year Longitudinal Study.
Martina Borghi, Sara Carletto, Luca Ostacoli, Francesco Scavelli, Lorenzo Pia, Simona Malucchi

Front Hum Neurosci· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis